A Research Study to Evaluate the Safety and Preliminary Efficacy of SGC001 in Patients With Myocardial Infarction

NCT07091929 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Anterior Myocardial Infarction

Interventions

DRUG: SGC001
DRUG: Placebo

Sponsor

Beijing Sungen Biomedical Technology Co., Ltd